The Wall Street analysts who cover Intersil Corporation (NASDAQ:ISIL) shares are providing price target projections on the company. They project that the shares will move to $19.785 within the upcoming year. The number they've arrived at is calculated by Zacks.com, long known as a provider of top-notch investment research. From the analysts polled by Zack's Research, the highest estimate stands at $22.5 and the lowest is at $15 for the stock.
Analyst Ratings In View
Zacks provides the average brokerage recommendation (ABR) for thousands of stocks for institutions and retail investors alike. This the calculated average of the actual recommendations (strong buy, hold, sell etc.) made for a given stock. The ABR is typically displayed with decimals (e.g. 1.52) versus the Zacks Rank, which is only shown in whole numbers (e.g. 1, 2, 3, etc.). This simplifies brokerage recommendations, which can become complicated. Intersil Corporation (NASDAQ:ISIL)'s shares currently have an ABR of 2.63.
During this fiscal period, Street analysts are projecting $0.15 earnings/share. This represents the current Zacks consensus EPS. For the period which closed on 2016-06-30, Intersil Corporation (NASDAQ:ISIL) dialed in an EPS of $0.12, creating a Surprise Factor of 0% (the difference between analyst projections and actual numbers). Curious investors will be awaiting 2016-10-26, the date when Intersil Corporation (NASDAQ:ISIL) will release their quarterly results.
During the most recent trading session, CVS Health Corporation (NYSE:CVS) shares traded +0.03%. Tracking the stock price in relation to moving averages may provide enhanced perspective on stock performance. After a recent look, the stock has been seen trading $-3.62 off of the 50-day moving average of $94.22 and $-7.27 separated from the 200-day moving average of $97.87. Taking a further look from a different perspective, the stock has been recently recorded -15.07% off of the 52-week high of 106.67 and +4.74% apart from the 52-week low of 86.50. Monitoring stock price activity relative to moving averages and the highs and lows for the past year might help with future stock price value assessment.
Price Target in Focus
While monitoring stock technicals is important, most investors are more concerned with where the stock might be going now. Equity research analysts have provided views on where they believe the stock will be trading in the future. According to Thomson Reuters, sell-side analysts are projecting a consensus target price of $111.07 on company shares. This is a near-term estimate for the next 12-18 months.
Currently, CVS Health Corporation Common S has a price to earnings ratio of 20.84. Analysts and investors may also opt to evaluate a company's PEG or price to earnings growth ratio. The stock currently has a PEG Ratio of 1.04.